• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Feldman Roman

    3/3/25 5:00:02 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology
    Get the next $GXAI alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Feldman Roman

    (Last) (First) (Middle)
    C/O GAXOS.AI INC.
    101 EISENHOWER PKWY, SUITE 300

    (Street)
    ROSELAND NJ 07068

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    03/03/2025
    3. Issuer Name and Ticker or Trading Symbol
    GAXOS.AI INC. [ GXAI ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Roman Feldman 03/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $GXAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GXAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GXAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gaxos Enters Multibillion-Dollar Digital Faith Market with Launch of Bible Pray AI

    Roseland, NJ, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Bible Pray AI, a personalized, AI-powered spiritual growth platform designed to help users deepen faith, strengthen daily devotion, and apply scripture for greater peace, clarity, and purpose. Bible Pray AI represents Gaxos' strategic expansion into the rapidly growing digital faith, mental wellness, and personal development economy, a sector supported by hundreds of millions of engaged global users seeking guided spiritual content, daily motivation, and community-base

    12/9/25 8:00:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    Gaxos to Participate in Upcoming WAWTech Conference on December 16th and 17th in Warsaw, Poland

    Roseland, NJ, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced its participation in the upcoming WAWTech Conference, taking place on December 16-17, 2025 in Warsaw, Poland. "We're thrilled to take part in this year's WAWTech Conference ," said Vadim Mats, CEO of Gaxos. "This event offers a tremendous opportunity to engage with technology leaders and innovators across Europe, exchange ideas, and build partnerships that accelerate the growth and adoption of Gaxos AI offerings." To meet with Gaxos at the conferences or for press inquiries, please email pre

    11/12/25 8:00:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    Gaxos Labs Launches "Photoshoots," Bringing Studio-Grade AI Photography to Art-Gen

    Gaxos Labs Expands Art-Gen Platform, Unlocking New Revenue Streams in the $250B Creator Economy Roseland, NJ, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the launch of Photoshoots, a major new feature for Art-Gen, an AI image and video creation platform that makes pro-grade content effortless for anyone, anywhere.  The feature update introduces an entirely new workflow that enables users to produce consistent, cinematic, studio-quality images and animations from any photo or concept in seconds. This release strengthens Gaxos' position in the rapid

    11/6/25 8:00:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Holzer Adam

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:03:36 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Grayson Scott

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:02:46 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Feldman Roman

    4 - GAXOS.AI INC. (0001895618) (Issuer)

    4/15/25 7:01:32 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    SEC Filings

    View All

    SEC Form 10-Q filed by Gaxos.ai Inc.

    10-Q - GAXOS.AI INC. (0001895618) (Filer)

    11/13/25 4:16:53 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    Gaxos.ai Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - GAXOS.AI INC. (0001895618) (Filer)

    8/13/25 4:15:59 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-Q filed by Gaxos.ai Inc.

    10-Q - GAXOS.AI INC. (0001895618) (Filer)

    8/13/25 4:00:23 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Gaxos.ai Inc.

    SC 13G - GAXOS.AI INC. (0001895618) (Subject)

    11/14/24 3:30:50 PM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Financials

    Live finance-specific insights

    View All

    Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App

    Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio

    3/13/24 8:30:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology

    $GXAI
    Leadership Updates

    Live Leadership Updates

    View All

    Gaxos Health Expands Medical Advisory Board

    Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D.  is a Board-Ce

    4/25/24 8:45:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology